Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
Roberta Gualtierotti, Associate Professor of Internal Medicine at University of Milan, shared on LinkedIn:
”Fc-fusion factors in orthopaedic surgery for haemophilia
Happy to share our experience at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Ospedale Policlinico di Milano, Università degli Studi di Milano, and Florence Hemophilia Center, Azienda Ospedaliero-Universitaria Careggi.
Prospective study (2018–2023) on 20 major surgeries in 19 patients with haemophilia A or B treated with rFVIIIFc or rFIXFc.
- Haemostasis rated ‘good’ in 95% of cases
- No transfusions required
- No treatment-related adverse events
- we need more date to standardize and personalize perioperative schedule with EHL factors
Conclusion: rFVIIIFc and rFIXFc ensured effective haemostasis and favourable safety in major orthopaedic surgery.”
Title: Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half-Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study
Authors: Luigi Piero Solimeno, Roberta Gualtierotti, Emanuele Guido, Jacopo Acquati Lozej, Enrica Cristini, Alessandro Ciavarella, Sara Arcudi, Christian Carulli, Lisa Pieri, Simona Maria Siboni, Flora Peyvandi
Read the full paper here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia